The ESCMID Study Group for Tick-Borne Diseases (ESGBOR) plays a pivotal role in the management of tick-borne diseases such as Lyme borreliosis. By uniting pan-European experts, ESGBOR is committed to:
Identification of potential biomarkers in active Lyme borreliosis.
Tjernberg I, Lager M, Furset Jensen G, Eikeland R, Nyman D, Brudin L, Henningsson AJ. PLoS ONE. 2023;18(6):e0287586.
International symposium on tick-borne pathogens and disease
22-25 October 2023, Vienna, Austria
If you have questions or comments for our study group, we warmly invite you to contact us!